Emily P. Thi
ORCID：0000-0003-2758-7561
发表论文 52 篇 · 总被引 1692 次 · h-index 18
代表论文
- Safety, pharmacokinetics, and antiviral activity of the capsid inhibitor AB‐506 from Phase 1 studies in healthy subjects and those with hepatitis B (2022 · Hepatology Communications · 被引 27)
- Control of Hepatitis B Virus with Imdusiran, a Small Interfering RNA Therapeutic (2024 · ACS Infectious Diseases · 被引 18)
- Measuring hepatitis B pgRNA stability using an updated automated HBV pgRNA assay with increased sensitivity (2023 · Hepatology Communications · 被引 15)
- Rational Design, Synthesis, and Structure–Activity Relationship of a Novel Isoquinolinone-Based Series of HBV Capsid Assembly Modulators Leading to the Identification of Clinical Candidate AB-836 (2024 · Journal of Medicinal Chemistry · 被引 13)
- Preclinical Antiviral and Safety Profiling of the HBV RNA Destabilizer AB-161 (2024 · Viruses · 被引 13)
- Reduction of hepatitis B surface antigen mediated by RNA interference therapeutic AB-729 in chronic hepatitis B patients is associated with T cell activation and a decline in exhausted CD8 T cells (2022 · Journal of Hepatology · 被引 11)